Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipients with Hepatocellular Carcinoma

BACKGROUND: The study objective was to evaluate the effect of everolimus (EVR) in combination with reduced tacrolimus (rTAC) compared with a standard TAC (sTAC) regimen on hepatocellular carcinoma (HCC) recurrence in de novo living-donor liver transplantation recipients (LDLTRs) with primary HCC at...

Descripción completa

Detalles Bibliográficos
Autores principales: Sapisochin, Gonzalo, Lee, Wei Chen, Joo, Dong Jin, Joh, Jae-Won, Hata, Koichiro, Soin, Arvinder Singh, Veldandi, Uday Kiran, Kaneko, Shuhei, Meier, Matthias, Leclair, Denise, Sunkara, Gangadhar, Jeng, Long Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700399/
https://www.ncbi.nlm.nih.gov/pubmed/36411723
http://dx.doi.org/10.12659/AOT.937988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700399/
https://www.ncbi.nlm.nih.gov/pubmed/36411723
http://dx.doi.org/10.12659/AOT.937988

Ejemplares similares